1. Home
  2. PFO vs IVVD Comparison

PFO vs IVVD Comparison

Compare PFO & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFO
  • IVVD
  • Stock Information
  • Founded
  • PFO 1991
  • IVVD 2020
  • Country
  • PFO United States
  • IVVD United States
  • Employees
  • PFO N/A
  • IVVD N/A
  • Industry
  • PFO Finance Companies
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFO Finance
  • IVVD Health Care
  • Exchange
  • PFO Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • PFO 120.4M
  • IVVD 123.8M
  • IPO Year
  • PFO N/A
  • IVVD 2021
  • Fundamental
  • Price
  • PFO $9.17
  • IVVD $0.54
  • Analyst Decision
  • PFO
  • IVVD Strong Buy
  • Analyst Count
  • PFO 0
  • IVVD 4
  • Target Price
  • PFO N/A
  • IVVD $7.89
  • AVG Volume (30 Days)
  • PFO 31.8K
  • IVVD 2.1M
  • Earning Date
  • PFO 01-01-0001
  • IVVD 03-20-2025
  • Dividend Yield
  • PFO 6.51%
  • IVVD N/A
  • EPS Growth
  • PFO N/A
  • IVVD N/A
  • EPS
  • PFO N/A
  • IVVD N/A
  • Revenue
  • PFO N/A
  • IVVD $25,384,000.00
  • Revenue This Year
  • PFO N/A
  • IVVD $606.63
  • Revenue Next Year
  • PFO N/A
  • IVVD $120.93
  • P/E Ratio
  • PFO N/A
  • IVVD N/A
  • Revenue Growth
  • PFO N/A
  • IVVD N/A
  • 52 Week Low
  • PFO $6.90
  • IVVD $0.36
  • 52 Week High
  • PFO $8.51
  • IVVD $4.24
  • Technical
  • Relative Strength Index (RSI)
  • PFO 45.81
  • IVVD 33.07
  • Support Level
  • PFO $9.12
  • IVVD $0.58
  • Resistance Level
  • PFO $9.23
  • IVVD $0.68
  • Average True Range (ATR)
  • PFO 0.07
  • IVVD 0.09
  • MACD
  • PFO -0.01
  • IVVD -0.02
  • Stochastic Oscillator
  • PFO 27.78
  • IVVD 0.00

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: